Blog Post Reviews Current R&D On Vaccines, Drugs For MERS

Global Health Technologies Coalition’s “Breakthroughs”: The latest in MERS R&D: Do we have the tools needed to prevent the next outbreak?
Kat Kelley, GHTC’s senior program assistant, reviews research and development efforts on vaccines and drugs for Middle East Respiratory Syndrome. She writes, “…Researchers and public health advocates alike are wondering: will we learn from the Ebola outbreak and invest in R&D to create the tools needed to respond to a MERS pandemic, or will we wait until it’s too late?” (8/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.